Join
Live feed
·
INSIDERFilingvia Quantisnow
Sagimet Biosciences Inc. logo

Executive Chairman Kemble George sold $289,979 worth of Series A Common Stock (37,688 units at $7.69), decreasing direct ownership by 32% to 81,005 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SGMT· Sagimet Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMT (Sagimet Biosciences Inc.) and more on Quantisnow.